FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W56508668> ?p ?o ?g. }

• W56508668 endingPage "9" @default.
• W56508668 startingPage "1315" @default.
• W56508668 abstract "Hepatocellular carcinoma patients with paraneoplastic syndromes usually have a larger tumor volume and a higher serum alpha-fetoprotein. Whether the presence of paraneoplastic syndromes, such as hypercholesterolemia, hypoglycemia, hypercalcemia, and erythrocytosis in hepatocellular carcinoma patients is a significant prognostic factor in patients' survival is of clinical interest.We evaluated the occurrence of paraneoplastic syndromes in 903 hepatocellular carcinoma patients; 179 (20%) patients developed paraneoplastic syndromes either upon diagnosis or during follow-up, 179 age-sex-tumor volume-matched hepatocellular carcinoma patients without paraneoplastic syndromes were selected as controls. Serum liver biochemistry, alpha-fetoprotein, clinical Child-Pugh's score, tumor image studies, histological features, accessibility to treatment, and survival were recorded and compared between patients with and without paraneoplastic syndromes. Prognostic factors in patients' survival were analyzed. The clinical course and survival of hepatocellular carcinoma patients with different paraneoplastic syndromes were also compared.Multivariate Cox regression analysis revealed Child-Pugh's grade C, ineligibility for active treatment, serum alpha-fetoprotein > 10,000 ng/mL, main portal vein tumor thrombosis, and the presence of paraneoplastic syndromes were all independent unfavorable prognostic factors for survival. The median survival from the occurrence of paraneoplastic manifestation to death was only 36 days. Patients with different paraneoplastic syndromes had similar clinical characteristics in Child-Pugh's score, serum alpha-fetoprotein level, tumor volume, prevalence of main portal vein tumor thrombosis, and accessibility for active treatment upon diagnosis. However, erythrocytosis and hypercholesterolemia usually developed earlier in the clinical course, whilst hypoglycemia and hypercalcemia were usually terminal events. Hepatocellular carcinoma patients with erythrocytosis tended to have a longer survival than patients with other paraneoplastic syndromes.The presence of paraneoplastic syndromes in hepatocellular carcinoma patients is an unfavorable prognostic factor, excluding the occurrence of erythrocytosis." @default.
• W56508668 created "2016-06-24" @default.
• W56508668 creator A5000562074 @default.
• W56508668 creator A5001655765 @default.
• W56508668 creator A5016301887 @default.
• W56508668 creator A5038739945 @default.
• W56508668 creator A5042673919 @default.
• W56508668 creator A5046698549 @default.
• W56508668 creator A5047674805 @default.
• W56508668 creator A5051235280 @default.
• W56508668 creator A5054235677 @default.
• W56508668 creator A5079454750 @default.
• W56508668 date "2002-09-21" @default.
• W56508668 modified "2023-10-18" @default.
• W56508668 title "Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes." @default.
• W56508668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12239934" @default.
• W56508668 hasPublicationYear "2002" @default.
• W56508668 type Work @default.
• W56508668 sameAs 56508668 @default.
• W56508668 citedByCount "26" @default.
• W56508668 countsByYear W565086682014 @default.
• W56508668 countsByYear W565086682015 @default.
• W56508668 countsByYear W565086682017 @default.
• W56508668 countsByYear W565086682018 @default.
• W56508668 countsByYear W565086682021 @default.
• W56508668 countsByYear W565086682022 @default.
• W56508668 countsByYear W565086682023 @default.
• W56508668 crossrefType "journal-article" @default.
• W56508668 hasAuthorship W56508668A5000562074 @default.
• W56508668 hasAuthorship W56508668A5001655765 @default.
• W56508668 hasAuthorship W56508668A5016301887 @default.
• W56508668 hasAuthorship W56508668A5038739945 @default.
• W56508668 hasAuthorship W56508668A5042673919 @default.
• W56508668 hasAuthorship W56508668A5046698549 @default.
• W56508668 hasAuthorship W56508668A5047674805 @default.
• W56508668 hasAuthorship W56508668A5051235280 @default.
• W56508668 hasAuthorship W56508668A5054235677 @default.
• W56508668 hasAuthorship W56508668A5079454750 @default.
• W56508668 hasConcept C121608353 @default.
• W56508668 hasConcept C126322002 @default.
• W56508668 hasConcept C142724271 @default.
• W56508668 hasConcept C143998085 @default.
• W56508668 hasConcept C2777546739 @default.
• W56508668 hasConcept C2778019345 @default.
• W56508668 hasConcept C2780868729 @default.
• W56508668 hasConcept C71924100 @default.
• W56508668 hasConcept C90924648 @default.
• W56508668 hasConceptScore W56508668C121608353 @default.
• W56508668 hasConceptScore W56508668C126322002 @default.
• W56508668 hasConceptScore W56508668C142724271 @default.
• W56508668 hasConceptScore W56508668C143998085 @default.
• W56508668 hasConceptScore W56508668C2777546739 @default.
• W56508668 hasConceptScore W56508668C2778019345 @default.
• W56508668 hasConceptScore W56508668C2780868729 @default.
• W56508668 hasConceptScore W56508668C71924100 @default.
• W56508668 hasConceptScore W56508668C90924648 @default.
• W56508668 hasIssue "47" @default.
• W56508668 hasLocation W565086681 @default.
• W56508668 hasOpenAccess W56508668 @default.
• W56508668 hasPrimaryLocation W565086681 @default.
• W56508668 hasRelatedWork W2016596724 @default.
• W56508668 hasRelatedWork W2045272277 @default.
• W56508668 hasRelatedWork W2134558634 @default.
• W56508668 hasRelatedWork W2144936227 @default.
• W56508668 hasRelatedWork W2473852705 @default.
• W56508668 hasRelatedWork W3018873590 @default.
• W56508668 hasRelatedWork W3090979210 @default.
• W56508668 hasRelatedWork W3091367366 @default.
• W56508668 hasRelatedWork W3155597877 @default.
• W56508668 hasRelatedWork W4240236077 @default.
• W56508668 hasVolume "49" @default.
• W56508668 isParatext "false" @default.
• W56508668 isRetracted "false" @default.
• W56508668 magId "56508668" @default.
• W56508668 workType "article" @default.